| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.61 | 0.04 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |